Abvc Biopharma, Inc. SEC filings ABVC
Abvc Biopharma, Inc. has 795 filings in SEC EDGAR's recent list, going back to Jun 28, 2002. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, agreement ended, new debt, unregistered share sale, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Shareholder vote results, Regulation FD disclosure
|
Nov 2, 2026 | Oct 30, 2026 |
| DEF 14A | Proxy statement | Sep 29, 2026 | Oct 28, 2026 |
| PRER14A | Revised preliminary proxy statement | Sep 11, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Aug 27, 2026 | Aug 27, 2026 |
| PRER14A | Revised preliminary proxy statement | Aug 25, 2026 | — |
| 424B4 | Prospectus | Aug 17, 2026 | — |
| 424B4 | Prospectus | Aug 17, 2026 | — |
| 424B4 | Prospectus | Aug 17, 2026 | — |
| 424B4 | Prospectus | Aug 17, 2026 | — |
| PRER14A | Revised preliminary proxy statement | Aug 12, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Other events
|
Aug 12, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Other events
|
Aug 4, 2026 | Aug 3, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 2, 2026 | Jul 2, 2026 |
| 10-Q | Quarterly report | May 18, 2026 | Mar 31, 2026 |
| NT 10-Q | Notification of late filing | May 15, 2026 | Mar 31, 2026 |
| POS AM | Post-effective amendment no. 5 to form s-1 | Mar 27, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Mar 27, 2026 | Mar 27, 2026 |
| DEF 14A | Proxy statement | Mar 5, 2026 | Mar 26, 2026 |
| 10-K | Annual report | Mar 3, 2026 | Dec 31, 2025 |
| 10-Q/A | Amended quarterly report | Mar 3, 2026 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Restatement
|
Mar 3, 2026 | Mar 3, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 5, 2026 | Feb 5, 2026 |
| 8-K/A |
Amended current report
Unregistered share sale
|
Jan 16, 2026 | Apr 30, 2025 |
| 424B4 | Prospectus | Nov 14, 2025 | — |
| 424B4 | Prospectus | Nov 14, 2025 | — |
| 424B4 | Prospectus | Nov 14, 2025 | — |
| 424B4 | Prospectus | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 30, 2025 | Oct 28, 2025 |
| 8-K/A |
Amended current report
Auditor change
|
Sep 12, 2025 | Oct 18, 2024 |
| 424B4 | Prospectus | Aug 15, 2025 | — |
| 424B4 | Prospectus | Aug 15, 2025 | — |
| 424B4 | Prospectus | Aug 15, 2025 | — |
| 424B4 | Prospectus | Aug 15, 2025 | — |
| 424B4 | Prospectus | Aug 15, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Jul 18, 2025 | Feb 8, 2024 |
| S-8 | Employee stock plan registration | Jun 27, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K/A |
Amended current report
Unregistered share sale
|
May 30, 2025 | Apr 30, 2025 |
| POS AM | Post-effective amendment no. 1 to form s-1 | May 27, 2025 | — |
| POS AM | Post-effective amendment no. 4 to form s-1 | May 27, 2025 | — |
| POS AM | Post-effective amendment no. 6 to form s-1 | May 27, 2025 | — |
| S-3 | Shelf registration | May 22, 2025 | — |
| EFFECT | Filing | May 20, 2025 | — |
| EFFECT | Filing | May 20, 2025 | — |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 3, 2025 |
| POS AM | Post-effective amendment no. 1 to form s-1 | May 16, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | May 16, 2025 | — |
| 8-K/A |
Amended current report
Unregistered share sale
|
May 14, 2025 | Apr 30, 2025 |
| 8-K/A |
Amended current report
Listing notice, Regulation FD disclosure
|
May 14, 2025 | Jul 12, 2024 |
| 8-K/A |
Amended current report
Listing notice
|
May 6, 2025 | Apr 30, 2025 |
| 8-K/A |
Amended current report
Restatement
|
May 2, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| 10-Q | Quarterly report | Apr 30, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice, Unregistered share sale
|
Apr 30, 2025 | Apr 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2025 | Apr 24, 2025 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Apr 16, 2025 | Apr 15, 2025 |
| 8-K |
Current report
Results of operations, Restatement, Regulation FD disclosure
|
Apr 15, 2025 | Apr 15, 2025 |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| NT 10-K | Notification of late filing | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2025 | Mar 5, 2025 |
| 8-K/A |
Amended current report
Listing notice, Regulation FD disclosure
|
Jan 13, 2025 | Jul 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 6, 2025 | Jan 6, 2025 |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 4, 2024 | Nov 4, 2024 |
| 424B4 | Prospectus | Oct 25, 2024 | — |
| 8-K |
Current report
Auditor change
|
Oct 18, 2024 | Oct 18, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2024 | Aug 20, 2024 |
| 424B4 | Prospectus | Aug 16, 2024 | — |
| 424B4 | Prospectus | Aug 16, 2024 | — |
| 424B4 | Prospectus | Aug 16, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 15, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 424B5 | Prospectus supplement | Aug 7, 2024 | — |
| 424B5 | Prospectus supplement | Aug 7, 2024 | — |
| EFFECT | Filing | Aug 1, 2024 | — |
| POS AM | Post-effective amendment no. 5 to form s-1 | Jul 26, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 23, 2024 | Jul 23, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 12, 2024 | Jul 12, 2024 |
| 424B4 | Prospectus | Jul 12, 2024 | — |
| EFFECT | Filing | Jul 1, 2024 | — |
| CORRESP | Letter to the SEC | Jun 27, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2024 | — |
| 8-K/A |
Amended current report
Material agreement
|
Jun 25, 2024 | Nov 16, 2023 |
| 8-K/A |
Amended current report
Material agreement
|
Jun 24, 2024 | Mar 26, 2024 |
| S-1 | Registration statement | Jun 21, 2024 | — |
| D | Filing | May 28, 2024 | — |
| 8-K |
Current report
Material agreement
|
May 24, 2024 | May 24, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 23, 2024 | May 23, 2024 |
| 424B4 | Prospectus | May 23, 2024 | — |
| 424B4 | Prospectus | May 22, 2024 | — |
| 424B4 | Prospectus | May 22, 2024 | — |
| 8-K/A |
Amended current report
Material agreement, Agreement ended
|
May 17, 2024 | Feb 8, 2024 |
| 10-Q | Quarterly report | May 17, 2024 | Mar 31, 2024 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Material agreement
|
May 9, 2024 | May 9, 2024 |
| EFFECT | Filing | Apr 30, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| POS AM | Post-effective amendment no. 3 to form s-1 | Apr 25, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 19, 2024 | Apr 19, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 17, 2024 | Apr 17, 2024 |
| 424B4 | Prospectus | Apr 5, 2024 | — |
| EFFECT | Filing | Apr 1, 2024 | — |
| CORRESP | Letter to the SEC | Mar 29, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 26, 2024 | Mar 26, 2024 |
| DEFA14A | Additional proxy material | Mar 25, 2024 | — |
| S-1/A | Amended registration statement | Mar 22, 2024 | — |
| 10-K/A | Amended annual report | Mar 15, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 14, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K/A |
Amended current report
Material agreement
|
Feb 29, 2024 | Jan 16, 2024 |
| 8-K/A |
Amended current report
Material agreement
|
Feb 29, 2024 | Nov 20, 2023 |
| S-1/A | Amended registration statement | Feb 16, 2024 | — |
| CORRESP | Letter to the SEC | Feb 16, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| S-1/A | Amended registration statement | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 9, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K/A | Amended current report | Jan 26, 2024 | Nov 16, 2023 |
| UPLOAD | Letter from the SEC | Jan 22, 2024 | — |
| 8-K/A |
Amended current report
Material agreement
|
Jan 17, 2024 | Nov 20, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jan 17, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 17, 2024 | Jan 17, 2024 |
| S-1 | Registration statement | Jan 12, 2024 | — |
| DEF 14A | Proxy statement | Dec 29, 2023 | Jan 16, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 15, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 20, 2023 | Nov 20, 2023 |
| 424B4 | Prospectus | Nov 17, 2023 | — |
| 424B4 | Prospectus | Nov 17, 2023 | — |
| 424B3 | Prospectus | Nov 17, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 15, 2023 | Sep 30, 2023 |
| NT 10-Q | Notification of late filing | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 13, 2023 | Sep 13, 2023 |
| 8-K/A |
Amended current report
Material agreement
|
Sep 6, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 31, 2023 | Aug 31, 2023 |
| 424B4 | Prospectus | Aug 17, 2023 | — |
| 424B4 | Prospectus | Aug 17, 2023 | — |
| 424B3 | Prospectus | Aug 17, 2023 | — |
| 8-K |
Current report
Material agreement
|
Aug 17, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K/A |
Amended current report
Listing notice
|
Aug 9, 2023 | Aug 22, 2022 |
| 8-K |
Current report
Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Material agreement
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 31, 2023 | Jul 31, 2023 |
| 424B5 | Prospectus supplement | Jul 31, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jul 27, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K/A |
Amended current report
Listing notice
|
Jul 14, 2023 | May 26, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 7, 2023 | Jul 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2023 | Jun 23, 2023 |
| DEF 14A | Proxy statement | Jun 21, 2023 | Jul 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 15, 2023 | Jun 15, 2023 |
| 424B4 | Prospectus | Jun 12, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| EFFECT | Filing | Jun 8, 2023 | — |
| S-1/A | Amended registration statement | Jun 8, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| S-1/A | Amended registration statement | Jun 7, 2023 | — |
| S-1/A | Amended registration statement | Jun 1, 2023 | — |
| CORRESP | Letter to the SEC | Jun 1, 2023 | — |
| PRE 14A | Preliminary proxy statement | May 31, 2023 | May 31, 2023 |
| 8-K |
Current report
Listing notice
|
May 26, 2023 | May 26, 2023 |
| 424B4 | Prospectus | May 22, 2023 | — |
| 424B3 | Prospectus | May 22, 2023 | — |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | May 11, 2023 | — |
| S-1/A | Amended registration statement | May 10, 2023 | — |
| CORRESP | Letter to the SEC | May 10, 2023 | — |
| UPLOAD | Letter from the SEC | May 3, 2023 | — |
| EFFECT | Filing | May 1, 2023 | — |
| EFFECT | Filing | May 1, 2023 | — |
| POS AM | Post-effective amendment no. 4 to form s-1 | Apr 26, 2023 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Apr 26, 2023 | — |
| S-1 | Registration statement | Apr 24, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 24, 2023 | Apr 24, 2023 |
| DEF 14A | Proxy statement | Apr 14, 2023 | Apr 24, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2023 | Apr 3, 2023 |
| 8-K/A |
Amended current report
Results of operations, Other events
|
Apr 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 31, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| D | Filing | Mar 2, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 24, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Listing notice
|
Feb 16, 2023 | Feb 16, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVC (Nasdaq), ECOC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1173313
- Former names
- American BriVision (Holding) Corp (until Apr 8, 2021); METU BRANDS, INC. (until Jan 8, 2016); Ecology Coatings, Inc. (until Sep 2, 2015); ECOLOGY COATINGS, INC. (until Sep 2, 2015); OCIS CORP (until Jun 13, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.